Join us wherever you are to explore the precise solutions needed for your unique diagnostic use case. Whether you are scaling digital pathology workflows or navigating complex regulatory landscapes, our global network ensures you have the exact expertise you need by your side. Partner with us to bridge the gap between groundbreaking technology and worldwide clinical adoption.
Bridge the gap between groundbreaking technology and clinical adoption. Navigate complex regulatory pathways, secure reimbursement, and scale digital pathology workflows to ensure your innovation reaches the patients who need it most.
Stop navigating opaque regulatory environments with generalist consultants who treat software as a medical device (SaMD) like any other product. Partner with experts who intimately understand the unique evidentiary requirements, clinical validation protocols, and spatial biology intricacies specific to AI-powered digital pathology.
Build robust quality management systems tailored explicitly for high-throughput pathology environments. Ensure seamless integration of novel diagnostics without disrupting existing laboratory compliance standards, maintaining absolute clinical safety from day one.
Translate Clinical Utility into Economic Value
Groundbreaking AI only saves lives when it is financially viable for clinics to adopt. Construct compelling health economic models that definitively prove return on investment (ROI). Empower laboratory directors and healthcare networks to see the immediate economic advantage of implementing your diagnostic algorithms.
Navigate the intricate and rapidly evolving landscape of digital pathology billing. Identify and secure the most advantageous Current Procedural Terminology (CPT) codes to maximize revenue capture and accelerate laboratory adoption.
Approach insurance providers with Humble Confidence. Present irrefutable clinical validity and health economic evidence to secure favorable coverage decisions, establish new reimbursement paradigms, and unlock localized funding pathways.
Transition smoothly from pilot programs to widespread clinical utilization. Launch highly specialized go-to-market plans that bypass generic messaging, directly engaging key opinion leaders (KOLs), leading oncologists, and global pathology networks.
Do not let inefficient laboratory workflows stifle diagnostic innovation. Architect scalable digital infrastructure that supports high-volume slide scanning, seamless AI analysis, and integrated Laboratory Information System (LIS) reporting. Achieve Unified Excellence by uniting hardware, software, and human expertise.
Operate with Honest Authenticity by promising — and executing — tangible operational improvements. Reduce turnaround times (TAT), minimize diagnostic errors, and empower pathologists to focus their expertise on complex oncology cases rather than manual counting.
AI = More testing. More access. More lives saved.
